Medical Equipment

Next-Generation Oncology Devices And Solutions Market Developments Shaping Growth Across The Forecast Period

April 14, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Next-Generation Oncology Devices And Solutions Market Projected To Reach By 2030? _x000D_

The market size for next-generation oncology devices and solutions has experienced rapid expansion in recent years. This market is projected to grow from $16.41 billion in 2025 to $19.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 18.6%. Historically, this expansion has been primarily due to increasing global cancer incidence rates, the expansion of molecular diagnostic capabilities, the availability of advanced oncology testing tools, the growth of hospital-based cancer care programs, and the rising adoption of targeted therapies._x000D_

_x000D_

The next-generation oncology devices and solutions market is poised for rapid expansion over the next few years. It is anticipated to reach $38.19 billion by 2030, growing at a compound annual growth rate (CAGR) of 18.4%. This growth during the forecast period can be attributed to factors such as increasing demand for personalized cancer treatment, rising investments in genomic diagnostics, the expansion of early screening programs, the growing integration of AI in oncology workflows, and advancements in biomarker-based cancer management. Major trends projected for this period include the increasing adoption of precision oncology platforms, the rising use of NGS-based cancer diagnostics, the growing integration of digital pathology solutions, the expansion of personalized cancer treatment approaches, and an enhanced focus on early detection technologies._x000D_

_x000D_

#Access Your Free Sample Report For In-Depth Market Analysis:#_x000D_

https://www.thebusinessresearchcompany.com/report/next-generation-oncology-devices-and-solutions-global-market-report_x000D_

_x000D_

Which Key Factors Are Driving The Next-Generation Oncology Devices And Solutions Market Growth?_x000D_

The growing incidence of cancer is anticipated to fuel the expansion of the next-generation oncology devices and solutions market in the future. Cancer is defined as a condition characterized by the uncontrolled proliferation of abnormal cells, which can metastasize and impair regular bodily functions. This escalating incidence of cancer is primarily attributable to aging populations, given that the likelihood of developing the disease escalates with advancing age. Next-generation oncology devices and solutions play a crucial role in managing the increasing burden of cancer through facilitating earlier detection, more accurate diagnosis, and tailored treatment approaches. For example, data from January 2024 released by the American Cancer Society, a nonprofit organization based in the US, projects that cancer will be responsible for over 611,000 fatalities in the United States, translating to more than 1,600 cancer-related deaths daily. Consequently, the expanding occurrence of cancer will act as a significant driver for the next-generation oncology devices and solutions market._x000D_

_x000D_

Which Segment Types Are Examined In The Next-Generation Oncology Devices And Solutions Market Segment Study?_x000D_

The next-generation oncology devices and solutions market covered in this report is segmented – _x000D_

_x000D_

1) By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer_x000D_

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), DNA Microarrays, Multiplexing, Other Technologies_x000D_

3) By Application: Screening And Early Detection, Prognostics And Monitoring, Therapy Selection, Recurrence Monitoring, Other Applications_x000D_

4) By End Use: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Uses_x000D_

_x000D_

Subsegments:_x000D_

1) By Breast Cancer: Invasive Ductal Carcinoma, Invasive Lobular Carcinoma, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer_x000D_

2) By Cervical Cancer: Squamous Cell Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma_x000D_

3) By Colorectal Cancer: Colon Cancer, Rectal Cancer, Metastatic Colorectal Cancer_x000D_

4) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Squamous Cell Lung Carcinoma_x000D_

_x000D_

Which Trends Are Guiding The Direction Of The Next-Generation Oncology Devices And Solutions Market?_x000D_

Companies operating in the next-generation oncology devices and solutions market are concentrating on technological advancements, such as next-generation sequencing (NGS) target enrichment solutions, to enhance the detection of rare genetic variants, improve sequencing accuracy, and expedite cancer diagnosis and treatment decisions. Next-generation sequencing (NGS) target enrichment solutions are methods that selectively capture and concentrate specific DNA or RNA regions for sequencing, allowing for a more accurate and efficient analysis of genetic variants linked to diseases like cancer. For example, in April 2025, Integrated DNA Technologies (IDT), a US-based biotechnology company, launched the xGen Hybridization and Wash v3 Kit, a revolutionary hybridization capture solution designed to accelerate cancer research by streamlining next-generation sequencing (NGS) workflows. This cutting-edge kit significantly reduces the hybridization time to just one hour, enabling researchers to complete sample preparation and proceed to sequencing within a single workday. By eliminating the need for heated buffers and decreasing hands-on time by 20%, the solution is highly automation-friendly and well-suited for high-throughput applications._x000D_

_x000D_

Which Players Are Part Of The Competitive Landscape Of The Next-Generation Oncology Devices And Solutions Market?_x000D_

Major companies operating in the next-generation oncology devices and solutions market are Johnson & Johnson Services Inc., Siemens AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc., Deep Bio Inc., Lucida Medical Ltd. _x000D_

_x000D_

#Get The Full Next-Generation Oncology Devices And Solutions Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/report/next-generation-oncology-devices-and-solutions-global-market-report_x000D_

_x000D_

Which Region Dominates The Next-Generation Oncology Devices And Solutions Market By Market Share?_x000D_

North America was the largest region in the next-generation oncology devices and solutions market in 2025. The regions covered in the next-generation oncology devices and solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request A Customized Next-Generation Oncology Devices And Solutions Market Report For Competitive Insights:#_x000D_

https://www.thebusinessresearchcompany.com/report/next-generation-oncology-devices-and-solutions-global-market-report_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Next-Generation Oncology Devices And Solutions Market 2026, By The Business Research Company#_x000D_

_x000D_

Interventional Oncology Devices Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report_x000D_

_x000D_

Oncology Drugs Market 2026_x000D_

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market_x000D_

_x000D_

Oncology Drugs Market 2026_x000D_

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market_x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_